DocMorris AG (XSWX:DOCM) Long-Term Debt: CHF286 Mil (As of Jun. 2025)


XSWX:DOCM DocMorris AG XSWX:DOCM
65 GF Score
Price CHF8.15
GF Value CHF10.53
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is DocMorris AG Long-Term Debt?

DocMorris AG XSWX:DOCM +2.97% 65 Long-Term Debt is CHF286 Mil as of Jun. 2025. GuruFocus rates XSWX:DOCM with a GF Score™ of 65/100 and a GF Value™ of CHF10.53 (Modestly Undervalued). The stock has 8 warning signs investors should review.

DocMorris AG's Long-Term Debt for the quarter that ended in Jun. 2025 was CHF286 Mil.

DocMorris AG's quarterly Long-Term Debt increased from Jun. 2024 (CHF284 Mil) to Dec. 2024 (CHF286 Mil) and increased from Dec. 2024 (CHF286 Mil) to Jun. 2025 (CHF286 Mil).

DocMorris AG's annual Long-Term Debt declined from Dec. 2022 (CHF460 Mil) to Dec. 2023 (CHF211 Mil) but then increased from Dec. 2023 (CHF211 Mil) to Dec. 2024 (CHF286 Mil).


DocMorris AG  (XSWX:DOCM) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


DocMorris AG Long-Term Debt Related Terms


DocMorris AG Long-Term Debt Historical Data

* Premium members only.

The historical data trend for DocMorris AG's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DocMorris AG Long-Term Debt Chart

DocMorris AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 483.92 485.41 460.20 211.44 285.82

DocMorris AG Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 334.19 211.44 284.19 285.82 286.00
XSWX:DOCM
65GF Score
DocMorris AG XSWX:DOCM
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of CHF286 Mil mean?
DocMorris AG (XSWX:DOCM) has a Long-Term Debt of CHF286 Mil as of Jun. 2025.
Is DocMorris AG's Long-Term Debt too high?
DocMorris AG's current Long-Term Debt is CHF286 Mil. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Long-Term Debt compare to competitors?
DocMorris AG's Long-Term Debt of CHF286 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. DocMorris AG's current Long-Term Debt is CHF286 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.53, compared to a current price of CHF8.15 — trading 22.6% below its estimated fair value. The current Long-Term Debt is CHF286 Mil. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current Long-Term Debt is CHF286 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?

Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued. The current stock price of CHF8.15 is trading 22.6% below its estimated GF Value™ of CHF10.53. GuruFocus considers DocMorris AG to be Modestly Undervalued.

Key valuation signals for XSWX:DOCM:

  • Long-Term Debt: CHF286 Mil
  • GF Value™: CHF10.53 vs. price of CHF8.15 (22.6% below fair value)
  • GF Score™: 65/100 with 8 warning signs

No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DocMorris AG Business Description

Other Exchanges DOCMz:UK0RRB:UKZRE:Germany
Address Walzmuhlestrasse 49, Frauenfeld, CHE, 8500
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score

Get the complete analysis for XSWX:DOCM

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF8.15
Price
CHF10.53
GF Value